Announce Date | 10/26/2024 |
EPS Normalized Actual | $0.39 (Beat by $0.04) |
EPS GAAP Actual | $0.39 (Beat by $0.04) |
Revenue Actual | $519.931B |
Revenue Surprise | Beat by $519931M |
Announce Date | 03/30/2025 (Pre-Market) |
EPS Normalized Estimate | $33.24391 |
EPS GAAP Estimate | $33.24391 |
Revenue Estimate | $286.868586423B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Mar 2028 | 197.07575 | 0.15 | 196.68851 | 197.5598 | 1 |
Mar 2027 | 163.81042 | 0.18 | 163.5875 | 164.08907 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 18.3 | -11.73289 | 519.931B | 100% | 257823.04M |
FQ3 2024 (Sep 2024) | 0.44 | -29.1837 | 507.172B | 100% | 250926.7M |
FQ2 1999 (Jun 1999) | 0.79 | 0.79 | 0B | NAN% | 0M |
FQ3 1999 (Sep 1999) | 7.75 | 7.75 | 0B | NAN% | 0M |
FQ4 1999 (Dec 1999) | 0.79 | 0.79 | 0.795652B | 100% | 795.65M |
FQ1 2000 (Mar 2000) | 0.82 | 0.82 | 1.14581B | 100% | 1145.81M |
FQ4 2009 (Dec 2009) | 3.75 | 3.75 | 0B | NAN% | 0M |
FQ1 2010 (Mar 2010) | 4.37 | 4.37 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2025 (Pre-Market)
Consensus EPS Estimates
33.24391
Consensus Revenue Estimates
286.868586423B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2026 (Mar 2026) | 39.47471 | -- | 39.47471 | 39.47471 | 0 |
FQ4 2025 (Oct 2025) | 34.87182 | 47.52 | 34.87182 | 34.87182 | 0 |
FQ3 2025 (Jul 2025) | 34.7523 | 98.73 | 34.7523 | 34.7523 | 0 |
FQ2 2025 (Jun 2025) | 34.7523 | -- | 34.7523 | 34.7523 | 0 |
FQ1 2025 (Mar 2025) | 33.24391 | -- | 33.24391 | 33.24391 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2026 (Mar 2026) | 754.17B | -- | 754.17B | 754.17B | 0 |
FQ4 2025 (Oct 2025) | 740.98B | 29.83 | 740.98B | 740.98B | 0 |
FQ3 2025 (Jul 2025) | 728.98B | 30.43 | 728.98B | 728.98B | 0 |
FQ2 2025 (Jun 2025) | 291.55B | -- | 291.55B | 291.55B | 0 |
FQ1 2025 (Mar 2025) | 286.87B | -- | 286.87B | 286.87B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
0
Revenue # of in-lines
4
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 30.03289 | 18.3 | -11.73289 | -64.11% |
FQ3 2024 (Sep 2024) | 29.6237 | 0.44 | -29.1837 | -6632.66% |
FQ2 1999 (Jun 1999) | 0.79 | 0.79 | 100% | |
FQ3 1999 (Sep 1999) | 7.75 | 7.75 | 100% | |
FQ4 1999 (Dec 1999) | 0.79 | 0.79 | 100% | |
FQ1 2000 (Mar 2000) | 0.82 | 0.82 | 100% | |
FQ4 2009 (Dec 2009) | 3.75 | 3.75 | 100% | |
FQ1 2010 (Mar 2010) | 4.37 | 4.37 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $262.11B | $519.93B | $257823.04M | 49.59% |
FQ3 2024 (Sep 2024) | $256.25B | $507.17B | $250926.7M | 49.48% |
FQ2 1999 (Jun 1999) | $0B | $0B | $0M | NAN% |
FQ3 1999 (Sep 1999) | $0B | $0B | $0M | NAN% |
FQ4 1999 (Dec 1999) | $0B | $0.8B | $795.65M | 100% |
FQ1 2000 (Mar 2000) | $0B | $1.15B | $1145.81M | 100% |
FQ4 2009 (Dec 2009) | $0B | $0B | $0M | NAN% |
FQ1 2010 (Mar 2010) | $0B | $0B | $0M | NAN% |